Burçin Şimşek
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Molecular Biology
- Cancer Research top 10%
- Immunology
- Co-authors
- Robert J. MotzerToni K. ChoueiriAndrea B. ApoloCristina SuárezJoshua ZhangThomas PowlesBernard EscudierAmishi Y. Shah
- Topics
- Renal cell carcinoma treatment (16 papers)Cancer Immunotherapy and Biomarkers (12 papers)Economic and Financial Impacts of Cancer (8 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Burçin Şimşek
38 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Pulmonary and Respiratory Medicine 600
- Oncology 508
- Molecular Biology 269
- Cancer Research 220
- Immunology 150
Countries citing papers authored by Burçin Şimşek
This map shows the geographic impact of Burçin Şimşek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burçin Şimşek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burçin Şimşek more than expected).
Fields of papers citing papers by Burçin Şimşek
This network shows the impact of papers produced by Burçin Şimşek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burçin Şimşek. The network helps show where Burçin Şimşek may publish in the future.
Co-authorship network of co-authors of Burçin Şimşek
This figure shows the co-authorship network connecting the top 25 collaborators of Burçin Şimşek. A scholar is included among the top collaborators of Burçin Şimşek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burçin Şimşek. Burçin Şimşek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 60 | |
| 3 | 13 | |
| 4 | 28 | |
| 5 | Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trialbreakdown → | 177 |
| 6 | 3 | |
| 7 | 11 | |
| 8 | 47 | |
| 9 | 257 | |
| 10 | 85 | |
| 11 | 11 | |
| 12 | 3 | |
| 13 | 2 | |
| 14 | 8 | |
| 15 | 10 | |
| 16 | 27 | |
| 17 | 57 | |
| 18 | 78 | |
| 19 | 14 | |
| 20 | 4 |
About Burçin Şimşek
Burçin Şimşek is a scholar working on Algebra and Number Theory, Discrete Mathematics and Combinatorics and Applied Mathematics, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Economic and Financial Impacts of Cancer (8 papers). The work is most often cited by research in Oncology (508 citations), Pulmonary and Respiratory Medicine (600 citations) and Cancer Research (220 citations). Burçin Şimşek has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Robert J. Motzer, Toni K. Choueiri, Andrea B. Apolo, Cristina Suárez, Joshua Zhang, Thomas Powles, Bernard Escudier, Amishi Y. Shah, Mauricio Burotto and María T. Bourlon. Their work appears in journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.